In the current study, JAK2 mutation was found to be prevalent in 28/100 (28%) of cases with idiopathic PVT and secondary causes (cases with another factor mutation or acquired risk factors for thrombophilia) were about 72/100 (72%) of while cases. This evidence concerns the gene JAK2 and Rare hereditary thrombophilia.